<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01226121</url>
  </required_header>
  <id_info>
    <org_study_id>IHtSC-Delay 101</org_study_id>
    <nct_id>NCT01226121</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture</brief_title>
  <official_title>A Post Market, Open-Label Study of the Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana Hand to Shoulder Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana Hand to Shoulder Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if of manipulation of digits following collagenase
      injection for treatment of Dupuytren's contracture is effected by the amount of time between
      injection and manipulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Metacarpophalangeal joint contractures caused by Dupuytren's disease will be
      evaluated as to the timing of the finger manipulation procedure that is performed following
      collagenase injection. Three groups will be evaluated: group 1 will have the manipulation
      procedure on the day following collagenase injection, group 2 will have the manipulation
      procedure on the second day following collagenase injection,and group 3 will have the
      manipulation procedure on the fourth day following collagenase injection,
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    difficulty enrolling additional patients
  </why_stopped>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients With Clinical Improvement (&gt; 50% Reduction in Contracture)</measure>
    <time_frame>30 days after injection</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Obtaining Clinical Success at 90 Days (&lt;=5 Degree Residual Contracture)</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Dupuytren's Disease</condition>
  <arm_group>
    <arm_group_label>Day 1 manipulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Finger manipulation one day following Clostridial collagenase injectable</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 2 manipulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Finger manipulation two days following Clostridial collagenase injectable</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 4 manipulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Finger manipulation four days following Clostridial collagenase injectable</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Clostridial collagenase injectable</intervention_name>
    <description>Finger manipulation performed 1, 2, or 4 days following collagenase injection</description>
    <arm_group_label>Day 1 manipulation</arm_group_label>
    <arm_group_label>Day 2 manipulation</arm_group_label>
    <arm_group_label>Day 4 manipulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult subjects (&gt; 18 years) of either gender with an metacarpophalangeal joint
             contracture and a palpable cord of &gt; 20 degrees of a digit (excluding the thumb) due
             to Dupuytren's contracture

        Exclusion Criteria:

          -  Any subject who has had prior surgical, percutaneous needle aponeurotomy or Xiaflex
             treatment for Dupuytren's contracture.

          -  Any subject using anti-coagulant therapy other than low dose aspirin (up to
             150mg/day).

          -  Any subject in the opinion of the MD investigators with chronic, severe or terminal
             medical illness which would make them unsuitable for study participation.

          -  Any subject with known allergy to Xiaflex (Clostridial collagenase).

          -  Any subject who cannot conform to the study visit schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>F. Thomas D. Kaplan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana Hand to Shoulder Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence C Hurst, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana Hand to Shoulder Center</name>
      <address>
        <city>Indianaplis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J; CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009 Sep 3;361(10):968-79. doi: 10.1056/NEJMoa0810866.</citation>
    <PMID>19726771</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2010</study_first_submitted>
  <study_first_submitted_qc>October 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2010</study_first_posted>
  <results_first_submitted>April 21, 2014</results_first_submitted>
  <results_first_submitted_qc>May 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 16, 2014</results_first_posted>
  <last_update_submitted>May 16, 2014</last_update_submitted>
  <last_update_submitted_qc>May 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana Hand to Shoulder Center</investigator_affiliation>
    <investigator_full_name>F. Thomas D. Kaplan, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>dupuytren</keyword>
  <keyword>dupuytren's</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Day 1 Manipulation</title>
          <description>Finger manipulation one day following collagenase injection</description>
        </group>
        <group group_id="P2">
          <title>Day 2 Manipulation</title>
          <description>Finger manipulation two days following collagenase injection</description>
        </group>
        <group group_id="P3">
          <title>Day 4 Manipulation</title>
          <description>Finger manipulation four days following collagenase injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>30 Day Evaluation</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Day 1 Manipulation</title>
          <description>Finger manipulation one day following collagenase injection</description>
        </group>
        <group group_id="B2">
          <title>Day 2 Manipulation</title>
          <description>Finger manipulation two days following collagenase injection</description>
        </group>
        <group group_id="B3">
          <title>Day 4 Manipulation</title>
          <description>Finger manipulation four days following collagenase injection</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="13"/>
            <count group_id="B4" value="37"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.9" spread="10.3"/>
                    <measurement group_id="B2" value="67" spread="6.4"/>
                    <measurement group_id="B3" value="65.5" spread="10.2"/>
                    <measurement group_id="B4" value="65.44" spread="9.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients With Clinical Improvement (&gt; 50% Reduction in Contracture)</title>
        <time_frame>30 days after injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 1 Manipulation</title>
            <description>Finger manipulation one day following collagenase injection</description>
          </group>
          <group group_id="O2">
            <title>Day 2 Manipulation</title>
            <description>Finger manipulation two days following collagenase injection</description>
          </group>
          <group group_id="O3">
            <title>Day 4 Manipulation</title>
            <description>Finger manipulation four days following collagenase injection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Clinical Improvement (&gt; 50% Reduction in Contracture)</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                    <measurement group_id="O2" value="91"/>
                    <measurement group_id="O3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Obtaining Clinical Success at 90 Days (&lt;=5 Degree Residual Contracture)</title>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Day 1 Manipulation</title>
            <description>Finger manipulation one day following collagenase injection</description>
          </group>
          <group group_id="O2">
            <title>Day 2 Manipulation</title>
            <description>Finger manipulation two days following collagenase injection</description>
          </group>
          <group group_id="O3">
            <title>Day 4 Manipulation</title>
            <description>Finger manipulation four days following collagenase injection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Obtaining Clinical Success at 90 Days (&lt;=5 Degree Residual Contracture)</title>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                    <measurement group_id="O2" value="82"/>
                    <measurement group_id="O3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>data collected for 90 day period patients were followed following injection</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Day 1 Manipulation</title>
          <description>Finger manipulation one day following collagenase injection</description>
        </group>
        <group group_id="E2">
          <title>Day 2 Manipulation</title>
          <description>Finger manipulation two days following collagenase injection</description>
        </group>
        <group group_id="E3">
          <title>Day 4 Manipulation</title>
          <description>Finger manipulation four days following collagenase injection</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Skin tear</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>pruritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated early due to slow enrollment</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>F. Thomas D. Kaplan</name_or_title>
      <organization>Indiana Hand to Shoulder Center</organization>
      <phone>3178759105</phone>
      <email>tdk@hand.md</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

